[Clinical use of a new beta-mimetic agent: Ritodrine (Du 21220)].
D000033:Abortion, Threatened / Q000517:prevention & control; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D007275:Injections, Intravenous; D007752:Obstetric Labor, Premature / Q000517:prevention & control; D010627:Phenethylamines / Q000008:administration & dosage / Q000627:therapeutic use*; D010636:Phenols / Q000008:administration & dosage / Q000627:therapeutic use; D011247:Pregnancy; D011412:Propanolamines / Q000008:administration & dosage / Q000627:therapeutic use*; D013566:Sympathomimetics / Q000008:administration & dosage / Q000627:therapeutic use*
D010627:Phenethylamines; D010636:Phenols; D011412:Propanolamines; D013566:Sympathomimetics
Uso clinico di un nuovo farmaco beta-mimetico: Ritodrina (du 21220.